Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 80/100

Becton Dickinson and Co at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 06:45PM GMT
Release Date Price: $235.58 (+0.18%)
Robert Adam Hopkins
BofA Securities, Research Division - MD of Equity Research

Okay. Great. Good afternoon, everybody. I'm Bob Hopkins from Bank of America, the U.S. medical device team here for the next fireside chat session. We're thrilled to have the senior management team from Becton, Dickinson, including Tom Polen, the company's President and CEO; Chris Reidy, who's the company's CFO and CAO; and, of course, Kristen Stewart, who is Senior Vice President, runs Investor Relations and Strategy.

Before we get going here, I want to hand it over to Kristen for a couple of intro remarks, and then we'll kick on. And thanks so much for being here. Really appreciate it.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Thanks, Bob.

So just as a reminder, during today's discussion, we may make some forward-looking statements, and it is possible that actual results could differ from our expectations. In particular, there continues to be significant uncertainty about the duration and contemplated impact of the COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot